PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, supplying promising improvements across many medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, more trusted alternate for therapeutic use, specifically in drug